AAAAAA

   
Results: 1-8 |
Results: 8
IN-VIVO GENE-THERAPY WITH A CATIONIC POLYMER MARKEDLY ENHANCES THE ANTITUMOR-ACTIVITY OF ANTIANGIOGENIC GENES
Authors: XU M CHEN QR KUMAR D STASS SA MIXSON AJ
Citation: M. Xu et al., IN-VIVO GENE-THERAPY WITH A CATIONIC POLYMER MARKEDLY ENHANCES THE ANTITUMOR-ACTIVITY OF ANTIANGIOGENIC GENES, MOLECULAR GENETICS AND METABOLISM, 64(3), 1998, pp. 193-197
GENE-THERAPY WITH P53 AND A FRAGMENT OF THROMBOSPONDIN-I INHIBITS HUMAN BREAST-CANCER IN-VIVO
Authors: XU M KUMAR D STASS SA MIXSON AJ
Citation: M. Xu et al., GENE-THERAPY WITH P53 AND A FRAGMENT OF THROMBOSPONDIN-I INHIBITS HUMAN BREAST-CANCER IN-VIVO, MOLECULAR GENETICS AND METABOLISM, 63(2), 1998, pp. 103-109
ONCOGENES AND TUMOR-SUPPRESSOR GENES - THERAPEUTIC IMPLICATIONS
Authors: STASS SA MIXSON AJ
Citation: Sa. Stass et Aj. Mixson, ONCOGENES AND TUMOR-SUPPRESSOR GENES - THERAPEUTIC IMPLICATIONS, Clinical cancer research, 3(12), 1997, pp. 2687-2695
PARENTERAL GENE-THERAPY WITH P53 INHIBITS HUMAN BREAST-TUMORS IN-VIVOTHROUGH A BYSTANDER MECHANISM WITHOUT EVIDENCE OF TOXICITY
Authors: XU M KUMAR D SRINIVAS S DETOLLA LJ YU SF STASS SA MIXSON AJ
Citation: M. Xu et al., PARENTERAL GENE-THERAPY WITH P53 INHIBITS HUMAN BREAST-TUMORS IN-VIVOTHROUGH A BYSTANDER MECHANISM WITHOUT EVIDENCE OF TOXICITY, Human gene therapy, 8(2), 1997, pp. 177-185
SYSTEMIC GENE-THERAPY WITH P53 REDUCES GROWTH AND METASTASES OF A MALIGNANT HUMAN BREAST-CANCER IN NUDE-MICE
Authors: LESOONWOOD LA KIM WH KLEINMAN HK WEINTRAUB BD MIXSON AJ
Citation: La. Lesoonwood et al., SYSTEMIC GENE-THERAPY WITH P53 REDUCES GROWTH AND METASTASES OF A MALIGNANT HUMAN BREAST-CANCER IN NUDE-MICE, Human gene therapy, 6(4), 1995, pp. 395-405
ADHD AND THE THYROID CONTROVERSY
Authors: HAUSER P ZAMETKIN AJ MARTINEZ P VITIELLO B MATOCHIK JA MIXSON AJ WEINTRAUB BD
Citation: P. Hauser et al., ADHD AND THE THYROID CONTROVERSY, Journal of the American Academy of Child and Adolescent Psychiatry, 33(5), 1994, pp. 756-757
ANALYSIS OF THE BINDING OF 3,3',5-TRIIODO-L-THYRONINE AND ITS ANALOGSTO MUTANT HUMAN BETA-1 THYROID-HORMONE RECEPTORS - A MODEL OF THE HORMONE-BINDING SITE
Authors: CHENG SY RANSOM SC MCPHIE P BHAT MK MIXSON AJ WEINTRAUB BD
Citation: Sy. Cheng et al., ANALYSIS OF THE BINDING OF 3,3',5-TRIIODO-L-THYRONINE AND ITS ANALOGSTO MUTANT HUMAN BETA-1 THYROID-HORMONE RECEPTORS - A MODEL OF THE HORMONE-BINDING SITE, Biochemistry, 33(14), 1994, pp. 4319-4326
DIFFERENTIAL EXPRESSION OF MUTANT AND NORMAL BETA-T3 RECEPTOR ALLELESIN KINDREDS WITH GENERALIZED RESISTANCE TO THYROID-HORMONE
Authors: MIXSON AJ HAUSER P TENNYSON G RENAULT JC BODENNER DL WEINTRAUB BD
Citation: Aj. Mixson et al., DIFFERENTIAL EXPRESSION OF MUTANT AND NORMAL BETA-T3 RECEPTOR ALLELESIN KINDREDS WITH GENERALIZED RESISTANCE TO THYROID-HORMONE, The Journal of clinical investigation, 91(5), 1993, pp. 2296-2300
Risultati: 1-8 |